20/20 Biolabs, Inc. Common Stock (NASDAQ: AIDX) last traded at $0.352, down 7.37% on the session. The quote above updates while this page is open; the figures below are drawn from 20/20 Biolabs, Inc. Common Stock’s own filings and are restated only when a new one is published.
20/20 Biolabs, Inc. Common Stock trades on NASDAQ under the ticker AIDX. Its market capitalisation is $4.50 million.
Valuation measures for 20/20 Biolabs, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.50M |
|---|---|
| Enterprise value | $2.91M |
| Price / sales | 2.20 |
| Price / book | 2.77 |
| Beta | 0.44 |
Trailing-twelve-month figures tagged in 20/20 Biolabs, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.05M |
|---|---|
| Net income (TTM) | -$3.74M |
| Gross margin | 29.56% |
| Operating margin | -162.87% |
| Return on equity | -230.69% |
| Cash | $4.55M |
Range and volume for AIDX over the past 52 weeks.
| 52-week high | $50.00 |
|---|---|
| 52-week low | $0.331 |
| Volume | 116.6K |
| Average volume | 92.7K |
| Previous close | $0.380 |
Invest a chosen dollar amount in 20/20 Biolabs, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AIDX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.